Screening and identification of a novel target specific for hepatoma cell line HepG2 from the FliTrx bacterial peptide library
Authors: Li, Wenhan; Lei, Ping; Yu, Bing1; Wu, Sha1; Peng, Jilin1; Zhao, Xiaoping1; Zhu, Huifen1; Kirschfink, Michael2; Shen, Guanxin
Source: Acta Biochimica et Biophysica Sinica, Volume 40, Number 5, May 2008 , pp. 443-451(9)
Publisher: Blackwell Publishing
Abstract:
To explore new targets for hepatoma research, we used a surface display library to screen novel tumor cell-specific peptides. The bacterial FliTrx system was screened with living normal liver cell line L02 and hepatoma cell line HepG2 successively to search for hepatoma-specific peptides. Three clones (Hep1, Hep2, and Hep3) were identified to be specific to HepG2 compared with L02 and other cancer cell lines. Three-dimensional structural prediction proved that peptides inserted into the active site of Escherichia coli thioredoxin (TrxA) formed certain loop structures protruding out of the surface. Western blot analysis showed that FliC/TrxA-peptide fusion proteins could be directly used to detect HepG2 cells. Three different FliC/TrxA-peptide fusion proteins targeted the same molecule, at approximately 140 kDa, on HepG2 cells. This work presented for the first time the application of the FliTrx library in screening living cells. Three peptides were obtained that could be potential candidates for targeted liver cancer therapy.Keywords: tumor target; hepatoma; bacterial display; FliTrx system; counter-screening; living-cell panning; 3-D modeling
Document Type: Research article
DOI: 10.1111/j.1745-7270.2008.00412.x
Affiliations: 1: Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China 2: Institute of Immunology, University of Heidelberg, 69120 Heidelberg, Germany

Click here for Page Help